Detalhe da pesquisa
1.
Targeted delivery of a PD-1-blocking scFv by CD133-specific CAR-T cells using nonviral Sleeping Beauty transposition shows enhanced antitumour efficacy for advanced hepatocellular carcinoma.
BMC Med
; 21(1): 327, 2023 08 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-37635247
2.
Cancer-Associated Fibroblast-Mediated Cellular Crosstalk Supports Hepatocellular Carcinoma Progression.
Hepatology
; 73(5): 1717-1735, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33682185
3.
Galectin-3 favours tumour metastasis via the activation of ß-catenin signalling in hepatocellular carcinoma.
Br J Cancer
; 123(10): 1521-1534, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32801345
4.
CIK cell cytotoxicity is a predictive biomarker for CIK cell immunotherapy in postoperative patients with hepatocellular carcinoma.
Cancer Immunol Immunother
; 69(5): 825-834, 2020 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-32060687
5.
HUS1 checkpoint clamp component (HUS1) is a potential tumor suppressor in primary hepatocellular carcinoma.
Mol Carcinog
; 58(1): 76-87, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30182378
6.
SKA1 overexpression is associated with poor prognosis in hepatocellular carcinoma.
BMC Cancer
; 18(1): 1240, 2018 Dec 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30537941
7.
Dendritic-cell-based immunotherapy evokes potent anti-tumor immune responses in CD105+ human renal cancer stem cells.
Mol Carcinog
; 56(11): 2499-2511, 2017 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-28621442
8.
Pooled safety analyses of ALK-TKI inhibitor in ALK-positive NSCLC.
BMC Cancer
; 17(1): 412, 2017 Jun 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-28606126
9.
Expression and prognostic role of ubiquitination factor E4B in primary hepatocellular carcinoma.
Mol Carcinog
; 55(1): 64-76, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25557723
10.
Annexin A3 as a potential target for immunotherapy of liver cancer stem-like cells.
Stem Cells
; 33(2): 354-66, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25267273
11.
Annexin A3 promotes tumorigenesis and resistance to chemotherapy in hepatocellular carcinoma.
Mol Carcinog
; 54(8): 598-607, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24375474
12.
[Cytokine-induced killer cells transfusion following minimally invasive and interventional therapy for early-stage hepatocellular carcinoma:a long-term study].
Zhonghua Yi Xue Za Zhi
; 95(33): 2668-72, 2015 Sep 01.
Artigo
em Zh
| MEDLINE | ID: mdl-26711819
13.
OK-432 synergizes with IFN-γ to confer dendritic cells with enhanced antitumor immunity.
Immunol Cell Biol
; 92(3): 263-74, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24296809
14.
Galectin-3 is associated with a poor prognosis in primary hepatocellular carcinoma.
J Transl Med
; 12: 273, 2014 Sep 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-25260879
15.
The phenotype of ex vivo generated cytokine-induced killer cells is associated with overall survival in patients with cancer.
Tumour Biol
; 35(1): 701-7, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23955802
16.
High expression of thymosin beta 10 predicts poor prognosis for hepatocellular carcinoma after hepatectomy.
World J Surg Oncol
; 12: 226, 2014 Jul 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-25037578
17.
PD-L1-expressing natural killer cells predict favorable prognosis and response to PD-1/PD-L1 blockade in neuroblastoma.
Oncoimmunology
; 13(1): 2289738, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38125723
18.
SMG5 Inhibition Restrains Hepatocellular Carcinoma Growth and Enhances Sorafenib Sensitivity.
Mol Cancer Ther
; 2024 Apr 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38647536
19.
N6-methyladenosine-modified VGLL1 promotes ovarian cancer metastasis through high-mobility group AT-hook 1/Wnt/ß-catenin signaling.
iScience
; 27(3): 109245, 2024 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38439973
20.
DNA of Neutrophil Extracellular Traps Binds TMCO6 to Impair CD8+ T-cell Immunity in Hepatocellular Carcinoma.
Cancer Res
; 84(10): 1613-1629, 2024 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38381538